Package 53746-925-05

{"route": ["ORAL"], "spl_id": "9ae72ba8-4a6b-4d01-b73e-0f1c9ae18711", "openfda": {"nui": ["N0000008486"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_set_id": ["0e21389b-2f51-4975-aa21-fc5c9dd9f6dc"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (53746-925-05)", "package_ndc": "53746-925-05", "marketing_start_date": "20230517"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (53746-925-60)", "package_ndc": "53746-925-60", "marketing_start_date": "20230517"}], "brand_name": "Lacosamide", "product_id": "53746-925_9ae72ba8-4a6b-4d01-b73e-0f1c9ae18711", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "53746-925", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "150 mg/1"}], "application_number": "ANDA204857", "marketing_category": "ANDA", "marketing_start_date": "20230517", "listing_expiration_date": "20261231"}